| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.41 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.24 | 0.4 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.23 | 0.5 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.18 | 0.6 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.2 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.5 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.3 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.065 | 0.4 |